Evidence map›Paper›PMID 36211091›Full record

ArticleCureus2022

Paracentral Acute Middle Maculopathy Associated With Cilioretinal Artery Insufficiency Following COVID-19 Vaccination in a Young Patient.

Dimitra Katerini, Myron Z Markakis, Vasiliki Kounali, Konstantina Koulotsiou, Dimitris Dimopoulos, Michail Nodarakis, Andreas Zacharioudakis, Pavlos Koutentakis

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Dimitra KateriniDepartment of Ophthalmology, Venizeleio General Hospital of Heraklion, Heraklion, GRC.
Myron Z MarkakisDepartment of Ophthalmology, Venizeleio General Hospital of Heraklion, Heraklion, GRC.
Vasiliki KounaliDepartment of Ophthalmology, Venizeleio General Hospital of Heraklion, Heraklion, GRC.
Konstantina KoulotsiouDepartment of Ophthalmology, G. Gennimatas General Hospital, Athens, GRC.
Dimitris DimopoulosDepartment of Ophthalmology, Venizeleio General Hospital of Heraklion, Heraklion, GRC.
Michail NodarakisDepartment of Ophthalmology, Venizeleio General Hospital of Heraklion, Heraklion, GRC.
Andreas ZacharioudakisDepartment of Ophthalmology, Venizeleio General Hospital of Heraklion, Heraklion, GRC.
Pavlos KoutentakisDepartment of Ophthalmology, Venizeleio General Hospital of Heraklion, Heraklion, GRC.
The General Hospital of Heraklion "Venizeleio-Pananio" · GRGeneral Hospital of Athens G. Genimatas · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aim to present a unique case of unilateral paracentral acute middle maculopathy (PAMM) associated with cilioretinal artery insufficiency following the coronavirus disease 2019 (COVID-19) vaccination. A 28-year-old male complained of a sudden blurring of vision in his left eye 40 days after receiving the second dose of COVID-19 immunization. The optical coherence tomography revealed a diffuse paracentral area of hyper-reflective change in the inner plexiform layer and an increase in the inner nuclear layer volume, consistent with PAMM along the course of the cilioretinal artery. PAMM has been connected to an assortment of retinal vasculature anomalies. Considering COVID-19 vaccination, we hypothesize that the immunogenic cascade following vaccination dysregulated coagulation and led to retinal vascular thrombosis. However, the link between COVID-19 vaccination and retinal vascular occlusion disease remains unknown.

Indexed as

cilioretinal arterycilioretinal artery insufficiencycovid-19 vaccineoptical coherence tomographyparacentral acute middle maculopathyretina and vaccinevisual acuity measurement

Identifiers

PMID36211091
PMCPMC9531696
OpenAlexW4294433613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.